BioStem Technologies, Inc. (BSEM) vs Lite Strategy, Inc. (LITS)

A side-by-side comparison of BioStem Technologies, Inc. and Lite Strategy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BioStem Technologies, Inc. logo
BSEM
BioStem Technologies, Inc.
$42M
$2.47HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Lite Strategy, Inc. logo
LITS
Lite Strategy, Inc.
$48M
$1.41HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BSEM vs LITS

growth of $100 · dividends reinvested · last 1y
BSEM -57.9% (-57.9%/yr)LITS -69.1% (-69.1%/yr)BSEM compounded faster over this window
20406080100120Start $1002026$42$31
BSEM LITS

BSEM vs LITS: by the numbers

  • •LITS is the larger company ($48M vs $42M market cap).
  • •Both run net losses; LITS's is the smaller (0.00% vs -13.86% net margin).

Metrics side by side

Valuation

MetricBSEMLITS
P/B ratio1.521.15

Profitability

MetricBSEMLITS
Gross margin93.13%0.00%
Operating margin-1.45%0.00%
Net margin-13.86%0.00%
ROE-102.45%-170.94%
ROIC-80.92%-30.75%

Growth (annualized)

MetricBSEMLITS
Total return CAGR (5Y)15.72%N/A

Go deeper

Full BSEM analysisFull LITS analysisInteractive comparison tool

Dig into the metrics

BioStem Technologies ROELite Strategy ROEBioStem Technologies operating marginLite Strategy operating marginBioStem Technologies revenue growthLite Strategy revenue growthBioStem Technologies free cash flowLite Strategy free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.